Clinical trial

Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer

NCT04543903

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-05-16

PhaseNA

Study timeline

Study start (actual)2022-05-16Date precision: day

Registry last updated2025-12-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Adenocarcinomaunresolved

Interventions

Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)DEVICE

Sponsors & collaborators

Alpha Tau Medical LTD.lead sponsor

Mapped research locations

HaifaIsrael2 Tel AvivIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04543903 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.